BI
BIOX.US Bioceres Crop Solutions Corp
- Market cap
- USD 13.4M
- P/E
- -
- P/B
- 1.75x
- ROE
- -589.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jun 2026.
Is BIOX.US undervalued?
Graham numberThe Graham number of Bioceres Crop Solutions Corp cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Bioceres Crop Solutions Corp fundamental analysis
No fundamental analysis for Bioceres Crop Solutions Corp yet.
Bioceres Crop Solutions Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Bioceres Crop Solutions Corp
Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions in Argentina, Brazil, the rest of Latin America, and internationally. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The company offers biological crop nutrition products comprising seed inoculants under the Rizoliq and UHC brands, biofertilizers, and biostimulants; biocontrol products, including bionematicide…
Full company profileBioceres Crop Solutions Corp financial statements
Bioceres Crop Solutions Corp annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 93.7M | 133M | 160M | 172M | 207M | 328M | 419M | 465M | 333M | 238M |
| Gross Profit | 33.8M | 56.4M | 73.6M | 79.5M | 90.9M | 126M | 184M | 182M | 128M | 82.4M |
| Operating Income | -707K | 15.7M | 32.1M | 39.1M | 38.4M | 39.9M | 53.0M | 44.8M | -762K | 100K |
| EBITDA | 3.90M | -12.8K | 17.3M | 30.6M | 43.7M | 47.9M | 62.3M | 55.5M | -9.76M | 100K |
| Net Income | -11.8M | -11.0M | -18.4M | 3.36M | -6.87M | -7.20M | 18.8M | 3.24M | -55.4M | -230M |
| EPS | -0.42 | -0.39 | -0.60 | 0.09 | -0.18 | -0.17 | 0.30 | 0.05 | -0.88 | -3.62 |
| Balance Sheet | ||||||||||
| Total Assets | 240M | 197M | 242M | 298M | 395M | 518M | 818M | 853M | 764M | 471M |
| Total Liabilities | 160M | 164M | 180M | 238M | 304M | 360M | 488M | 501M | 468M | 407M |
| Shareholders' Equity | 38.3M | 33.1M | 47.3M | 45.5M | 67.7M | 128M | 299M | 315M | 263M | 39.1M |
| Cash & Short-term Investments | 1.68M | 2.23M | 3.81M | 56.0M | 46.8M | 38.6M | 60.1M | 56.2M | 34.7M | 12.2M |
| Total Debt | 75.0M | 91.0M | 104M | 150M | 175M | 170M | 257M | 271M | 277M | 237M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 19.1M | 18.4M | 29.7M | 9.32M | -6.21M | -17.5M | 2.59M | 41.7M | 49.9M | 52.6M |
| Capital Expenditure | 1.39M | 5.71M | 3.45M | 4.50M | 13.9M | 9.00M | 22.6M | 22.8M | 14.6M | 1.05M |
| Free Cash Flow | 17.7M | 12.7M | 26.2M | 4.82M | -20.1M | -26.5M | -20.0M | 18.9M | 35.3M | 51.6M |
| Ratios | ||||||||||
| ROE | -30.8% | -33.3% | -38.8% | 7.4% | -10.1% | -5.6% | 6.3% | 1.0% | -21.1% | -589.0% |
| ROA | -4.9% | -5.6% | -7.6% | 1.1% | -1.7% | -1.4% | 2.3% | 0.4% | -7.3% | -48.9% |
| Net Profit Margin | -12.6% | -8.3% | -11.5% | 1.9% | -3.3% | -2.2% | 4.5% | 0.7% | -16.6% | -96.8% |
| Debt to Equity | 1.96x | 2.75x | 2.19x | 3.29x | 2.58x | 1.33x | 0.86x | 0.86x | 1.05x | 6.06x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Bioceres Crop Solutions Corp dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | - | - | - |
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | USD 1.03M | 0.03 | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Bioceres Crop Solutions Corp
- Insiders 16.85%
- Institutions 22.86%
- Public & others 60.29%
- Shares outstanding 63.8M
- Free float 45.3M
Top funds holding BIOX.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Global X MSCI Argentina ETF | 1.11M | 1.74% | 0.00% | Oct 2026 |
| ACATIS Datini Valueflex Fonds A | 70.0K | 0.11% | 0.00% | Sep 2026 |
| Fidelity Nasdaq Composite Index | 23.8K | 0.04% | 0.00% | Aug 2026 |
Top institutions holding BIOX.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Solel Partners LP | 4.58M | 7.18% | 0.00% | Jun 2026 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 1.41M | 2.20% | +30.98% | Jun 2026 |
| Long Focus Capital Management, LLC | 830K | 1.30% | 0.00% | Jun 2026 |
| Ardsley Advisory Partners | 475K | 0.74% | 0.00% | Jun 2026 |
| UBS Group AG | 408K | 0.64% | +13.99% | Jun 2026 |
| Susquehanna International Group, LLP | 213K | 0.33% | -1.14% | Jun 2026 |
| PNC Financial Services Group Inc | 133K | 0.21% | 0.00% | Jun 2026 |
| The Goldman Sachs Group Inc | 129K | 0.20% | +10.76% | Jun 2026 |
| Ping Capital Management, Inc. | 55.0K | 0.09% | 0.00% | Jun 2026 |
| Jane Street Group LLC | 36.3K | 0.06% | +6.33% | Jun 2026 |
| Two Sigma Investments LLC | 30.0K | 0.05% | -68.50% | Jun 2026 |
| Stifel Financial Corp | 29.6K | 0.05% | -64.39% | Jun 2026 |
| Geode Capital Management, LLC | 23.8K | 0.04% | -39.02% | Jun 2026 |
| One Degree Advisors Inc | 23.0K | 0.04% | 0.00% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 18.0K | 0.03% | -0.26% | Jun 2026 |
| Group One Trading, LLC | 15.3K | 0.02% | +28.45% | Jun 2026 |
| Tower Research Capital LLC | 9.55K | 0.02% | 0.00% | Jun 2026 |
| MJT & Associates Financial Advisory Group, Inc | 1.49K | 0.00% | 0.00% | Jun 2026 |
| J.Safra Asset Management Corp | 1.40K | 0.00% | 0.00% | Jun 2026 |
| Advisor Group Holdings, Inc. | 1.21K | 0.00% | 0.00% | Jun 2026 |
Bioceres Crop Solutions Corp company profile
- Company name
- Bioceres Crop Solutions Corp
- Ticker
- BIOX.US
- ISIN
- KYG1117K1141
- Exchange
- USA Stocks
- Listed since
- Mar 22, 2018
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 562
- Fiscal year end
- June
- Address
- Ocampo 210 bis, Rosario, Argentina, 2000
- Phone
- 54 34 1486 1100
- Website
- investors.biocerescrops.com
About Bioceres Crop Solutions Corp
Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions in Argentina, Brazil, the rest of Latin America, and internationally. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The company offers biological crop nutrition products comprising seed inoculants under the Rizoliq and UHC brands, biofertilizers, and biostimulants; biocontrol products, including bionematicides, biofungicides, and bioinsecticides; crop nutrition and crop protection products, such as micro-beaded fertilizers and adjuvants; and seed germplasms, GMO and non-GMO traits, and ready-to-use seed treatment pack solutions for healthier and higher yielding crops. It also provides fungicide products under the Rizoderma brand; Rizofos for foliar applications; therapies, herbicides, and baits; and bio-inductors, crop health products, and biological and micro granulated fertilizers. In addition, the company licenses its HB4 seed trait for drought tolerance in wheat and soybean seeds. It sells its products to blue-chip companies and industry leaders, large distributors, co-ops, dealers, large farmers, and individual growers through distributors and dealers. The company was founded in 2001 and is headquartered in Rosario, Argentina.
Bioceres Crop Solutions Corp management
5- Jose A. RoqueGeneral Counsel & Chief Compliance Officer
- Dr. Federico Trucco Ph.D.CEO & Executive Director · born 1977
- Mr. Ezequiel SimmermacherChief Financial Officer · born 1986
- Mr. Alejandro VillafanePrincipal Accounting Officer
- Ms. Maria Paula SavantiHead of Investor Relations